rs768633670
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_153682.3(PIGP):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000737 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_153682.3 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGP | NM_153682.3 | c.2T>C | p.Met1? | start_lost | Exon 2 of 5 | ENST00000360525.9 | NP_710149.1 | |
PIGP | NM_001320480.2 | c.2T>C | p.Met1? | start_lost | Exon 2 of 5 | NP_001307409.1 | ||
PIGP | NM_153681.2 | c.74T>C | p.Met25Thr | missense_variant | Exon 1 of 4 | NP_710148.1 | ||
PIGP | NM_016430.4 | c.-243T>C | 5_prime_UTR_variant | Exon 2 of 6 | NP_057514.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251494Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135922
GnomAD4 exome AF: 0.0000773 AC: 113AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.0000743 AC XY: 54AN XY: 727234
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74352
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 55 Pathogenic:4
ACMG classification criteria: PS3 supporting, PS4 supporting, PM2 moderate, PM3 moderate, PP1 supporting -
- -
The c.2T>C;p.(Met1?) is a start-loss variant in the PIGP gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevant exon to the transcript -PVS1_supporting. Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product (PMID: 28334793) - PS3_supporting. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 397551; PMID: 28334793; 32042915; 31139695) - PS4. The variant is present at low allele frequencies population databases (rs768633670 - gnomAD 0.0003943%; ABraOM 0.000854 frequency - http://abraom.ib.usp.br/) - PM2_supporting. The p.(Met1?) was detected in trans with a pathogenic variant (PMID: 28334793; 32042915) - PM3. In summary, the currently available evidence indicates that the variant is likely pathogenic. -
- -
PIGP-related disorder Pathogenic:1
The PIGP c.2T>C variant is predicted to disrupt the translation initiation site (Start loss). This variant has been reported in the compound heterozygous state and to segregate with disease in four individuals from two families affected with PIGP-related disorders (Johnstone et al. 2017. PubMed ID: 28334793; Martín-Grau C et al. 2023. PubMed ID: 37125481). Functional studies in vitro indicate that this variant impacts protein function through reduced PIGP protein expression and reduced cell surface expression of GPI-anchored proteins (Johnstone et al. 2017. PubMed ID: 28334793). This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD. Based on the available evidence, we classify this variant as likely pathogenic. -
See cases Pathogenic:1
ACMG classification criteria: PS3, PS4, PM2, PM3 -
not provided Pathogenic:1
This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 25 of the PIGP protein (p.Met25Thr). This variant is present in population databases (rs768633670, gnomAD 0.006%). This missense change has been observed in individual(s) with early infantile epileptic encephalopathy (PMID: 28334793). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 397551). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects PIGP function (PMID: 28334793). For these reasons, this variant has been classified as Pathogenic. -
Early infantile epileptic encephalopathy with suppression bursts Uncertain:1
This variant was found in a compound heterozygous state with c.456delA. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at